Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-29
DOI
10.1186/s12944-023-01947-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
- (2023) Antonio Olveira et al. Life-Basel
- Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study
- (2022) Jing Zeng et al. Hepatobiliary & Pancreatic Diseases International
- Optimal Threshold of Homeostasis Model Assessment of Insulin Resistance to Identify Metabolic Syndrome in a Chinese Population Aged 45 Years or Younger
- (2022) Szu-Yu Lin et al. Frontiers in Endocrinology
- Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease
- (2022) Dongna Zhao et al. Annals of Hepatology
- Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
- (2022) Yamei Duan et al. Frontiers in Immunology
- Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
- (2022) Moritz Peiseler et al. JOURNAL OF HEPATOLOGY
- MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men
- (2022) Tsubasa Tsutsumi et al. Diabetology & Metabolic Syndrome
- Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence
- (2022) C. Tong et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
- (2022) Ho Soo Chun et al. LIVER INTERNATIONAL
- Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
- (2022) Yanhua Zhao et al. Frontiers in Endocrinology
- Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
- (2021) Moritz Peiseler et al. Cancers
- Systemic inflammatory response index as an independent risk factor for ischemic stroke in patients with rheumatoid arthritis: a retrospective study based on propensity score matching
- (2021) Zihan Jin et al. CLINICAL RHEUMATOLOGY
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
- (2021) Tsubasa Tsutsumi et al. HEPATOLOGY RESEARCH
- Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease
- (2021) Shiwei Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study
- (2021) Xiaomo Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China
- (2021) Yebei Liang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population
- (2021) Jiahua Fan et al. Nutrition & Metabolism
- Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study
- (2021) Cheng Yu et al. Journal of Clinical and Translational Hepatology
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups
- (2021) Ibrahim Ayada et al. LIVER INTERNATIONAL
- Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
- (2021) Pietro Torre et al. Frontiers in Medicine
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis
- (2020) Yuankai Wu et al. Hepatology International
- Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
- (2020) Hiren Mandaliya et al. Translational Lung Cancer Research
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
- (2020) Ai-Ping Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Changing NAFLD Epidemiology in China
- (2019) Hye Won Lee et al. HEPATOLOGY
- Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab
- (2019) Jingjing Liu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Non‐alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management
- (2019) Tony (Dazhong) Huang et al. INTERNAL MEDICINE JOURNAL
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population
- (2017) Ren-Nan Feng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
- (2016) Bin Gao et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Epidemiology and natural history of non-alcoholic fatty liver disease
- (2016) Yousef Fazel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pathobiology of liver fibrosis: a translational success story
- (2015) Youngmin A Lee et al. GUT
- The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma
- (2014) Akiyoshi Kinoshita et al. ANNALS OF SURGICAL ONCOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started